🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-01
Trial ID
NCT01397409
Treatments Being Tested
Retinal vein occlusion (RVO) may lead to series of complications including ...
Status
Unknown
Location
Chuangxin Huang
Start Date
2019-10-01
Trial ID
NCT04062370
Treatments Being Tested
This is a 12 month study of monthly injections of ranibizumab in subjects w...
Status
Completed
Location
Retina Consultants of Hawaii
Start Date
2007-01
Trial ID
NCT00424710
Treatments Being Tested
This is a phase 4 prospective, nonrandomized, open label, interventional cl...
Status
Completed
Location
Southeast Retina Center
Start Date
2015-06
Trial ID
NCT03340610
Treatments Being Tested
Objectives: Primary objective: To evaluate the effects on retinal morphop...
Status
Unknown
Location
Retina and Vitreous service of the University Hospital, Faculty of Medicine of Ribeirão Preto-USP (HCFMRP)
Start Date
2012-02
Trial ID
NCT02005432
This is a 24-week, prospective, multi-center, open-label, randomized, inves...
Status
Terminated
Location
Toronto Retina Institue
Start Date
2015-11
Trial ID
NCT02684084
This is a two-part study. The first part (Stratum I) is an open-label, dose...
Status
Completed
Location
Retina Consultants of Arizona
Start Date
2012-02
Trial ID
NCT01445899
Treatments Being Tested
The aim of this study is to test if PF582 (ranibizumab) is safe and similar...
Status
Completed
Location
Eye Institute
Start Date
2013-11
Trial ID
NCT02121353
This study investigates the use of radiation to treat wet age-related macul...
Status
Completed
Location
Bristol Eye Hospital
Start Date
2014-12
Trial ID
NCT02243878
Treatments Being Tested
This study will examine the use of Aflibercept in patients with exudative m...
Status
Completed
Location
Cole Eye Institute, Cleveland Clinic
Start Date
2012-06
Trial ID
NCT01617148
Treatments Being Tested